**Introduction** {#sec1}
================

Huntington disease (HD) has been mainly reported in the West and, to date, knowledge on HD in China is very sparse. It has been claimed, that the incidence is very low, however, well-conducted epidemiological studies are lacking. Furthermore, the phenotype in HD patients has not been well characterized, and it may well be that it is influenced by ethnic background. We have therefore performed an analysis of the literature on HD China by systematically retrieving appropriate reports to describe the clinical manifestations of the disease in this country.  

**Methods** {#sec2}
===========

Items including Huntington's disease, Chinese equivalents of the terms: hereditary chorea, chronic progressive chorea, and hysterical chorea were used as keywords to search articles published in the China National Knowledge Infrastructure. Pre-indexing did not reveal any systematic evaluation, prospective or retrospective cohort study regarding HD in China. Case series and individual reports published between January 1^st^, 1980 and April 30^th^, 2011 were included, but reviews and experimental studies on HD excluded. Case reports with non-definite clinical diagnosis or repetitive contents were excluded. Information was extracted about family history, involuntary movements, including the region involved, cognitive disturbances, and psychiatric symptoms. Results of imaging and neurophysiological studies, and of genetic testing were included, where available.   

**Literature inclusion** {#sec3}
------------------------

A total of 230 articles related to HD were collected; 136 were excluded since they reported identical data and basic studies; 94 studies involving 547 patients were selected (Table 1). Of these, 306 cases ad to be excluded due to incomplete clinical data. In total, 279 patients were included (157 males and 122 females), with an age of onset of 6--70 years. Of these cases, 236 cases (96.8%) included a family history. A total of 89 patients were noted to have come from a precise region, 16 were from the South, and the remainder were from the North (82.0%), including 15 from Henan Province, 14 from Shandong Province, and 8 from Hebei Province.

Table 1. Reports included in the present survey    

Year of publicationFirst authorMaleFemaleMolecular testingRef.  NAge at onsetNAge at onset  1980Wancong Gao0na1nana[@ref-1046804543] 1980Linde Liu142127na[@ref-426118220] 1980Wenshi Li237 to 42154na[@ref-1188623259] 1980Xiongya Wu151147na    [@ref-1963005097] 1983Qian Xu515 to 4437 to 8na[@ref-185620348]1984Zian Chen432 to 39132na[@ref-1492337928] 1985Xiaolian Du25 to 40316 to 19na[@ref-2675103732] 1985Jixue Feng0na141na[@ref-3520198248] 1985Shuyou Fang428 to 46124na[@ref-3256360752] 1986Guiqing Wang228 to 58128 to 58na[@ref-2901946024] 1986Honglin Fu0na334na[@ref-1768441905] 1986Hua Shao1390nana[@ref-3965275347] 1987Wenjun Chen1310nana[@ref-3713342616] 1988Shicheng Pei1430nana[@ref-2322541101] 1988Shuqiang Bu0na234 to 37na[@ref-577962357] 1988Keqing Ding341 to 55145na[@ref-472750831] 1988Zhiyuan Ha128130na[@ref-3520409497] 1989Yongqian Xing520 to 35325 to 43na[@ref-945099995] 1989Xuesong Tu0na1nana[@ref-1441501239] 1989Fuyuan Shao170nana[@ref-657669637] 1990Yuxiang Xu417 to 42135na[@ref-4231286099] 1990Chuandong Wu217 to 360nana[@ref-129462184] 1990Jiaxi Huang0na434 to 40na[@ref-834857684] 1991Zhaoxiang Zeng0na131na[@ref-3736207284] 1992Ke Fan427 to 38238 to 56na[@ref-3527715928] 1992Changdao Sun324 to 30221 to 25na[@ref-1361923140] 1992Chengyu Chen427 to 470nana[@ref-1111889778] 1993Fengying Hou1470nana[@ref-1337597950] 1994Yanjun Gao1480nana[@ref-2818592113] 1994Qishan Dong142138na[@ref-2104750889] 1994Yuejin Huang0na142na[@ref-2694822854] 1995Xiaomei Yao0na246 to 47na[@ref-165452473] 1995Xiuhua Fan1470nana[@ref-4071333552] 1995Chenghao Chu410 to 65120na[@ref-3914278448] 1995Jiying Wang0na132na[@ref-1511932677] 1995Ronghua Yong160148na[@ref-3507549914] 1996Kun Liu0na142na[@ref-1442276519] 1996Zhaozhong Shen2na0nana[@ref-431705654] 1997Meiju Hou1360nana[@ref-486891569] 1997Jiaming Xia318 to 35218na[@ref-1275446189] 1997Wenhua Sun0na125na[@ref-4219975259] 1998Xiangming Fang518 to 400nana[@ref-3921550393] 1998Weizhou Liu1230nana[@ref-962209450] 1998Yujin Zhang624 to 50430 to 55na[@ref-2099551473] 1998Xiaoping Yang230 to 40213 to 33na[@ref-1888517549] 1998Kai Feng1560nana[@ref-3252481735] 1998Zuozhi Gao233 to 54134na[@ref-4107546331] 1998Xiaoping Zeng343 to 54145na[@ref-700223663] 1998Yuchen Sun142245 to 46na[@ref-3041678919] 1999Weiguo Yang0na139na[@ref-808531999] 1999Guilan Wang0na18na[@ref-1111092004] 1999Bin Liu432 to 45334 to 38na[@ref-930670673] 2001Xi Zhang1500nana[@ref-1813956066] 2001Jing Chen1240nana[@ref-3050225771] 2001Wen Li221 to 26325 to 26na[@ref-1713818247] 2001Qinglin Dong423 to 36230 to 32na[@ref-3597223271] 2001Huizhi Fan0na132na[@ref-666041106] 2001Liansheng Xu529 to 54532 5o 52na[@ref-84952942] 2002Jing Liu328 to 46535 to 50na[@ref-1450994747] 2002Benqiang Deng1660nana[@ref-3519424995] 2002Ye Tian170140na[@ref-1630850833] 2003Liqun Fang1310nana[@ref-1737960849] 2003Huize Ma231 to 52333 to 45na[@ref-766402950] 2003Yuhai Zhao222 to 40130N CAG repeats[@ref-2404485412] 2004Feng Tian154238 to 50na[@ref-1178694636] 2004Mingbing Chen1320nana[@ref-2001379017] 2004Weiwei Dong1140nana[@ref-2524917065] 2004Jun Chen252244 to 54na[@ref-2001379017] 2004Jiamu Wu231 to 330nana[@ref-426929820] 2004Beilei Zhu1280naGenetic test (no N CAG repeats)[@ref-45580129] 2005Liyan Guo0na132na[@ref-372500488] 2006Shiyong Zhang0na152na[@ref-2500780941] 2006Huamei Wang241 to 480nana[@ref-631457270] 2006Fang Lin4421 to 580nana[@ref-2913934466] 2006Baorong Zhang330 to 45518 to 36N CAG repeat[@ref-837468433] 2006Zhilin Shi233 to 45145Genetic test (no N CAG repeats)[@ref-140772958] 2007Yuan Liu333117N CAG repeats[@ref-1444209463] 2007Yanchun Geng228 to 290nana[@ref-2298680351] 2008Wei Xu325 to 36227 to 45Genetic test (no N CAG repeats)[@ref-1122917166] 2008Jin Yu141432 to 45na[@ref-3437981768] 2008Ning Wang1na2naN CAG repeat[@ref-2935057038] 2008Zhouri Li240 to 43141na[@ref-1479063331] 2008Yiming Feng1330nana[@ref-4242937726] 2009Xingwang Song241 to 5746 to 58N CAG repeat[@ref-1512559547] 2009Qiuhong Zheng250 to 60341 to 60na[@ref-1888224440] 2009Meiying Cai130235 to 45N CAG repeat[@ref-303374294] 2009Weijie Liu0na137na[@ref-1061675318] 2010Meihua Zhu0na135na[@ref-1072689055] 2010Ge Gao336 to 420naN CAG repeat[@ref-2387140583] 2010Jing Ma0na146na[@ref-215617064] 2011Min Li0na151na[@ref-1207212771]  Total157122  

     Most (65%) of the patients had onset in middle age (Table2), with a mean of 35.8 years (± 11.8), mean age at death was 45.6 years (± 13.5, range 13--69), and mean course from onset to death was of 11.6 years (± 5.6, range 3--30). Around 9 % had a juvenile onset. The study included 115 families. Paternal inheritance was more often found than maternal inheritance (Table 2), and age of onset with paternal inheritance was lower than maternal inheritance (34 ± 10 versus 37 ± 10 years,*P* \< 0.05). The age at death (46 ± 15 *vs*. 50 ± 10 years), and the course of disease (12 ± 6 *vs*. 12 ± 4 years), were not significantly different. In addition, no difference was found between male and female patients in terms of age of onset, death age (47 ± 14 versus 46 ± 12 years), and course of disease (12 ± 6.0 *vs*. 10.7 ± 5.0 years). Within the cohort, 55 patients death were reported, of which three were due to suicide.

 Table 2. Clinical features of the reported patients  

 N of total with available data%Inheritance  Paternal127/19465.5Maternal67/19434.5Anticipation42/5971.2Age at onset (yr)  \< 2024/2798.630--55182/27965.2Presentation at onset  Abnormal movements146/19652.3Generalized94/14664.4Head and face20/14613.7Upper limbs29/14619.8Lower limbs3/1462.1Psychiatric disorder45/19616.1Cognitive impairment5/1961.8Course  Abnormal movements242/24399.6Psychiatric disorder85/24335.0Cognitive impairment165/24367.9

   The most frequent presentation at onset were abnormal movement found in more than half of the patients (Table 2), with a predilection for the face and upper limbs when it was not generalized. In the course of the disorder most patients developed abnormal movements, followed by psychiatric symptoms and cognitive impairment (Table 2). There were some specific features in single patients, for example, one displayed speech impairment, instability of gait and cognitive impairment, with no obvious involuntary movement [@ref-2524917065]. Dysarthria and dysphagia was also reported during the course in 26 % of the patients. One single patient had epilepsy at onset.

**Laboratory investigations** {#sec4}
-----------------------------

     In a total of 48 patients with electroencephalograms, 34 (70.8%) had abnormal curves, mostly with mild slowing. In a total of 16 patients undergoing cerebrospinal fluid examination, three (18.8%) displayed abnormally increased protein levels. In a total of 89 patients undergoing cranial imaging, 80 (90.0%) presented with abnormalities of varying extent, including 65 (73.0%) with brain atrophy and lateral ventriculomegaly, 2 (2.2%) with selective caudate nucleus atrophy, and 26 (29.2%) with brain atrophy, lateral ventriculomegaly, and caudate nucleus atrophy. *IT15*gene detection was reported positive in 38 patients, of which CAG repeats were clearly reported in 33 of the cases. The number of CAG repeats was greater in patients with a younger age of onset (mean of 61 in patients with onset before versus 46 with age of onset after 30).   

**Discussion** {#sec5}
==============

The prevalence of HD is quite variable, with figures varying between 0.5 (Finland)[@ref-2570778026], 1 (Croatia [@ref-964885372]) and 10 (German speaking European countries [@ref-146022288]) per 100 000 in Europe, and with high local prevalence in some communities, like in Venezuela (almost 700 in the Lake Maracaibo region [@ref-897322579]. It is usually thought that the prevalence in Asia is lower, however, fewer data than in the West have been reported so far. In Japan reported estimations ranged between 0.1 [@ref-1505446255] and 0.7 [@ref-4002592542]. Earlier estimation in Hongkong are within the same range [@ref-1255473940], however, no data have been so far reported for mainland China. The present survey of Chinese literature on HD shows that the disease is indeed present in this country, but does not provide precise clues on the prevalence of the disorder. It also suggests a higher prevalence in Northern China, however this may also be a report bias. The number of juvenile cases reported seems higher than in other regions of the world and there is a male predominance in overall prevalence. However, the mean age of onset is otherwise consistent, but the course seems shorter with absence of the gender difference reported earlier [@ref-3785319020]. The majority of patients had a positive family history, and only five cases were determined to be sporadic. Moreover, the number of cases due to paternal inheritance was significantly greater than that from maternal inheritance, with a significantly younger age of onset with paternal inheritance, which was in accordance with previously published results. Only one case among the 20 with juvenile onset was reported to have epileptic seizure, which is in contrast to the literature, reporting up to 30% of them. Studies have suggested that the suicide rate of HD patients is significantly greater than healthy individuals, in particular in early or advanced stages [@ref-580344739]. Only three patients were reported to have committed suicide, however, data regarding suicide in China are not available for comparison. In general the other aspects were similar to the reports in other populations. However, only a small number had a molecular confirmed diagnosis, but the trend to earlier age of onset with higher triplet repeat numbers is found here also.

     In conclusion, ethnic differences among Chinese with HD as compared to other populations are possible. However, the use of appropriate clinical assessment tools and molecular genetic testing in a larger cohort of patients is urgently needed. For this reason a Chinese Huntington's disease network is going to be launched.   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